{"id":"W2622725967","doi":"10.1002/hon.2437_107","title":"COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Progressive disease; Gastroenterology; Rituximab; Lymphoma; Clinical endpoint; Refractory (planetary science); Phases of clinical research; Follicular lymphoma; Oncology; Surgery; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004617185,0.0002456209,0.0005631821,0.0002705258,0.0001903456,0.0004019571,0.0001882758,0.0002032531,0.001145354],"category_scores_gemma":[0.0004214226,0.0001093623,0.000220518,0.0003292704,0.0001471443,0.0002029413,0.0001510706,0.0003841809,0.0002203575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004799132,"about_ca_system_score_gemma":0.0005493017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005907763,"about_ca_topic_score_gemma":0.002778833,"domain_scores_codex":[0.9998597,0.00004792782,0.00001200506,0.00003252173,0.00002455449,0.00002319604],"domain_scores_gemma":[0.9997851,0.00005236119,0.0000765174,0.00000867257,0.00001279199,0.00006464485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04719149,0.001466667,0.4390963,0.00164226,0.0009281623,0.003473189,0.0003845741,0.002205497,0.05291577,0.0003438393,0.01335973,0.4369926],"study_design_scores_gemma":[0.01343664,0.03357784,0.8989679,0.0003287812,0.001265713,0.008842712,0.0002538896,0.004207585,0.01130062,0.0005529263,0.02721596,0.0000494916],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983982,0.01262098,0.0002265859,0.0002870045,0.00002673147,0.0001234569,0.0005463905,0.00004102519,0.002145803],"genre_scores_gemma":[0.994804,0.002470504,0.0005608998,0.0004030345,0.00005616585,0.0001133409,0.001082279,0.000005826941,0.0005038431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001145354,"threshold_uncertainty_score":0.003831625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03686729126405178,"score_gpt":0.3419778960514678,"score_spread":0.305110604787416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}